These results strongly suggest that the binding of FSCN1 to PTK6 mRNA could enhance the phosphorylation of AKT and GSK3β, thereby facilitating the progression of ESCC. The gene discussed is FSCN1; the disease is esophageal squamous cell carcinoma.